Komori
Earnings presentation2907AHJIKAN CO.,LTD.Food

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027

During the interim period of the fiscal year ending March 2027, consolidated net sales, operating profit, ordinary profit and net income exceeded the year-earlier period, due to increased sales of food products for commercial use, lower raw material prices and improved production efficiency. Meanwhile, health food sales and profit declined.

Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
659
¥ million (interim consolidated operating profit)
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportSecond quarter (interim period) of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥25,658 million+102.9%
Operating profit¥659 million+333.4%
Ordinary income¥733 million+181.4%
Net income¥486 million+170.8%
Gross Profit Margin27 %
Operating profit margin2.6 %
Selling, general and administrative expenses¥6,260 million
Full-year earnings forecast
Net Sales
¥54,500 million
Operating profit
¥1,500 million
Ordinary income
¥1,700 million
Profit attributable to owners of the parent
¥1,150 million
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Uncertain and volatile factors, including winter raw material prices such as those for eggs, foreign exchange rates and stock prices
Key KPIsA metric the company considers important as a management benchmark.
  • Sales of food products for commercial use¥23,544 million+103.3%
  • Food products for commercial use segment profit¥1,529 million+160.6%
  • Health food sales¥1,903 million+99.2%
  • Health food segment profit¥84 million+67.6%
  • Equity ratio63.9 %
Segment results
Commercial food products
Net Sales
¥23,544 million+103.3%
Segment profit
¥1,529 million+160.6%
Health Food
Net Sales
¥1,903 million+99.2%
Segment profit
¥84 million+67.6%
Other
Net Sales
¥211 million+92.1%
Segment profit
¥8 million
Financial targets
ROIC
5 %
Target fiscal yearFiscal year ending March 2027
ROE
6 %
Target fiscal yearFiscal year ending March 2027
DOE
2.5 %
Target fiscal yearFiscal year ending March 2027
Number of employees
Number of Employees887 people
Capital expenditures
¥1,190 million
Annual Dividend
58 yen per share
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredSecond quarter (interim period) of the fiscal year ending March 2027
Net Sales¥25,658 million (YoY +102.9%)
Operating profit¥659 million (YoY +333.4%)
Ordinary income¥733 million (YoY +181.4%)
Net income¥486 million (YoY +170.8%)
Gross Profit Margin27 %
Operating profit margin2.6 %
Selling, general and administrative expenses¥6,260 million
Full-year earnings forecastNet Sales ¥54,500 million / Operating profit ¥1,500 million / Ordinary income ¥1,700 million / Profit attributable to owners of the parent ¥1,150 million
Segment resultsCommercial food products Net Sales ¥23,544 million (YoY +103.3%) / Segment profit ¥1,529 million (YoY +160.6%) / Health Food Net Sales ¥1,903 million (YoY +99.2%) / Segment profit ¥84 million (YoY +67.6%) / Other Net Sales ¥211 million (YoY +92.1%) / Segment profit ¥8 million
Key KPIsSales of food products for commercial use ¥23,544 million (YoY +103.3%), Food products for commercial use segment profit ¥1,529 million (YoY +160.6%), Health food sales ¥1,903 million (YoY +99.2%), Health food segment profit ¥84 million (YoY +67.6%), Equity ratio 63.9 %
Number of employeesNumber of Employees 887 people / Change during the period Not disclosed / Hiring plan Not disclosed
Assumptions Underlying the Business OutlookUncertain and volatile factors, including winter raw material prices such as those for eggs, foreign exchange rates and stock prices
Financial targetsROIC 5 % / ROE 6 % / DOE 2.5 %
Annual Dividend58 yen per share
Capital expenditures¥1,190 million
Items this document does not state (14)
Results for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In food products for commercial use, demand for egg omelet products increased among supermarkets, the food-service industry and lodging facilities in Japan. Overseas demand for thick omelets and crab-flavored kamaboko also increased, expanding export sales. In addition, egg prices remained slightly below the previous year, while improved production efficiency lowered the manufacturing cost ratio. Health food profit declined due to a decrease in the number of regular mail-order customers, lower sales, an increase in the manufacturing cost ratio and the implementation of strategic advertising and promotional activities.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 | AHJIKAN CO.,LTD. (2907) timely disclosure | Komori